These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 29863899)

  • 1. Risk Factors for Asthma Exacerbation and Treatment Failure in Adults and Adolescents with Well-controlled Asthma during Continuation and Step-Down Therapy.
    DiMango E; Rogers L; Reibman J; Gerald LB; Brown M; Sugar EA; Henderson R; Holbrook JT
    Ann Am Thorac Soc; 2018 Aug; 15(8):955-961. PubMed ID: 29863899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with failure of emergency department management in children with acute moderate or severe asthma: a prospective, multicentre, cohort study.
    Ducharme FM; Zemek R; Chauhan BF; Gravel J; Chalut D; Poonai N; Guertin MC; Quach C; Blondeau L; Laberge S;
    Lancet Respir Med; 2016 Dec; 4(12):990-998. PubMed ID: 27451347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β
    Bleecker ER; FitzGerald JM; Chanez P; Papi A; Weinstein SF; Barker P; Sproule S; Gilmartin G; Aurivillius M; Werkström V; Goldman M;
    Lancet; 2016 Oct; 388(10056):2115-2127. PubMed ID: 27609408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.
    Sobieraj DM; Weeda ER; Nguyen E; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE; Baker WL
    JAMA; 2018 Apr; 319(14):1485-1496. PubMed ID: 29554195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Simple Score for Future Risk Prediction in Patients with Controlled Asthma Who Undergo a Guidelines-Based Step-Down Strategy.
    Pérez de Llano L; García-Rivero JL; Urrutia I; Martínez-Moragón E; Ramos J; Cebollero P; Carballada F; Blanco-Aparicio M; Vennera MDC; Merino M; Torralba-García Y; Plaza V
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1214-1221.e3. PubMed ID: 30368006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Step-Down Therapy for Asthma Well Controlled on Inhaled Corticosteroid and Long-Acting Beta-Agonist: A Randomized Clinical Trial.
    Rogers L; Sugar EA; Blake K; Castro M; Dimango E; Hanania NA; Happel KI; Peters SP; Reibman J; Saams J; Teague WG; Wise RA; Holbrook JT;
    J Allergy Clin Immunol Pract; 2018; 6(2):633-643.e1. PubMed ID: 28974349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial.
    Beasley RW; Donohue JF; Mehta R; Nelson HS; Clay M; Moton A; Kim HJ; Hederer BM
    BMJ Open; 2015 Feb; 5(2):e006131. PubMed ID: 25649209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of asthma exacerbation among patients with poorly controlled asthma despite inhaled corticosteroid treatment.
    Quezada W; Kwak ES; Reibman J; Rogers L; Mastronarde J; Teague WG; Wei C; Holbrook JT; DiMango E
    Ann Allergy Asthma Immunol; 2016 Feb; 116(2):112-7. PubMed ID: 26712474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Step-down treatment from medium-dosage of budesonide/formoterol in controlled asthma.
    Mori K; Fujisawa T; Inui N; Hashimoto D; Enomoto N; Nakamura Y; Kuroishi S; Yokomura K; Toyoshima M; Imokawa S; Yamada T; Shirai T; Masuda M; Hayakawa H; Chida K; Suda T
    Respir Med; 2016 Oct; 119():1-6. PubMed ID: 27692128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FourFold Asthma Study (FAST): a study protocol for a randomised controlled trial evaluating the clinical cost-effectiveness of temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations.
    Skeggs A; McKeever T; Duley L; Mitchell E; Bradshaw L; Mortimer K; Walker S; Parrott S; Wilson A; Pavord I; Brightling C; Thomas M; Price D; Devereux G; Higgins B; Harrison T; Haydock R
    Trials; 2016 Oct; 17(1):499. PubMed ID: 27737713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial corticosteroid therapy for asthma.
    Gibson PG; Powell H
    Curr Opin Pulm Med; 2006 Jan; 12(1):48-53. PubMed ID: 16357579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of asthma control: the SERENA study.
    Corrado A; Renda T; Polese G; Rossi A;
    Respir Med; 2013 Nov; 107(11):1659-66. PubMed ID: 24045118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
    Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A
    Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.